Correlation Between Edgewise Therapeutics and Alx Oncology
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Alx Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Alx Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Alx Oncology Holdings, you can compare the effects of market volatilities on Edgewise Therapeutics and Alx Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Alx Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Alx Oncology.
Diversification Opportunities for Edgewise Therapeutics and Alx Oncology
-0.87 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Edgewise and Alx is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Alx Oncology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alx Oncology Holdings and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Alx Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alx Oncology Holdings has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Alx Oncology go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Alx Oncology
Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the Alx Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Edgewise Therapeutics is 1.64 times less risky than Alx Oncology. The stock trades about -0.05 of its potential returns per unit of risk. The Alx Oncology Holdings is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 145.00 in Alx Oncology Holdings on September 2, 2024 and sell it today you would earn a total of 3.00 from holding Alx Oncology Holdings or generate 2.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Alx Oncology Holdings
Performance |
| Timeline |
| Edgewise Therapeutics |
| Alx Oncology Holdings |
Edgewise Therapeutics and Alx Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Alx Oncology
The main advantage of trading using opposite Edgewise Therapeutics and Alx Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Alx Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alx Oncology will offset losses from the drop in Alx Oncology's long position.| Edgewise Therapeutics vs. Tff Pharmaceuticals | Edgewise Therapeutics vs. Eliem Therapeutics | Edgewise Therapeutics vs. Inhibrx | Edgewise Therapeutics vs. Enliven Therapeutics |
| Alx Oncology vs. Tff Pharmaceuticals | Alx Oncology vs. Eliem Therapeutics | Alx Oncology vs. Inhibrx | Alx Oncology vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |